{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T18:05:56Z","timestamp":1779300356305,"version":"3.51.4"},"reference-count":169,"publisher":"BMJ","license":[{"start":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T00:00:00Z","timestamp":1779235200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Thorax"],"accepted":{"date-parts":[[2026,2,20]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Idiopathic pulmonary fibrosis (IPF) is a progressive, fatal interstitial lung disease characterised by excessive extracellular matrix deposition, leading to respiratory failure. While the exact aetiology of IPF remains unclear, growing evidence suggests that immune dysregulation plays a pivotal role in its pathogenesis. Recent research highlights the involvement of conventional (CD4\n                      <jats:sup>+<\/jats:sup>\n                      , CD8\n                      <jats:sup>+<\/jats:sup>\n                      T cells as well as B cells), and unconventional T cell subsets, including natural killer T cells and mucosal-associated invariant T cells in fibrotic lung disease. Unconventional T cell subsets are known for their rapid response to stress signals, antigen-independent activation and involvement in tissue homeostasis and repair. Their potential to modulate fibrosis through interactions with fibroblasts, macrophages and epithelial cells positions them as key players in lung injury and repair mechanisms.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This review explores the current knowledge of both conventional and unconventional lymphocytes in IPF, examining their contributions to fibrosis development and their potential as therapeutic targets.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>By elucidating their functions and interactions within the lung microenvironment, we provide insights into novel immunomodulatory strategies for IPF treatment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/thorax-2024-222059","type":"journal-article","created":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T17:20:24Z","timestamp":1779297624000},"page":"thorax-2024-222059","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Breaking with convention: the role of lymphocytes in IPF"],"prefix":"10.1136","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1242-5455","authenticated-orcid":false,"given":"Kelly L","family":"Short","sequence":"first","affiliation":[{"name":"School of Medical, Molecular and Forensic Sciences, Murdoch University, Murdoch, Western Australia, Australia"},{"name":"Institute for Respiratory Health, The University of Western Australia, Nedlands, Western Australia, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donal","family":"O\u2019Malley","sequence":"additional","affiliation":[{"name":"University College Dublin, Dublin, Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerard","family":"Hoyne","sequence":"additional","affiliation":[{"name":"The School of Health Sciences, The University of Notre Dame Australia, Perth, Western Australia, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc","family":"Hertz","sequence":"additional","affiliation":[{"name":"GRI Bio Inc, La Jolla, California, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Albert","family":"Agro","sequence":"additional","affiliation":[{"name":"GRI Bio Inc, La Jolla, California, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vipin","family":"Kumar","sequence":"additional","affiliation":[{"name":"GRI Bio Inc, La Jolla, California, USA"},{"name":"Laboratory of Immune Regulation, UCSD School of Medicine, La Jolla, California, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cecilia M","family":"Pr\u00eale","sequence":"additional","affiliation":[{"name":"School of Medical, Molecular and Forensic Sciences, Murdoch University, Murdoch, Western Australia, Australia"},{"name":"Institute for Respiratory Health, The University of Western Australia, Nedlands, Western Australia, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2736-8174","authenticated-orcid":false,"given":"Adam","family":"J Byrne","sequence":"additional","affiliation":[{"name":"University College Dublin - National University of Ireland, Dublin, Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2026,5,20]]},"reference":[{"key":"2026052010201446000_thorax-2024-222059v1.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmed.2016.02.004"},{"key":"2026052010201446000_thorax-2024-222059v1.2","doi-asserted-by":"crossref","DOI":"10.1038\/s41420-023-01344-x","article-title":"T cells in idiopathic pulmonary fibrosis: crucial but controversial","volume":"9","author":"Deng","year":"2023","journal-title":"Cell Death Discov"},{"key":"2026052010201446000_thorax-2024-222059v1.3","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01469-2021","article-title":"Plasma cell but not CD20-mediated B-cell depletion protects from bleomycin-induced lung fibrosis","volume":"60","author":"Pr\u00eale","year":"2022","journal-title":"Eur Respir J"},{"key":"2026052010201446000_thorax-2024-222059v1.4","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1183\/13993003.01114-2024","article-title":"Distinct mural cells and fibroblasts promote pathogenic plasma cell accumulation in idiopathic pulmonary fibrosis","volume":"65","author":"Yang","year":"2025","journal-title":"Eur Respir J"},{"key":"2026052010201446000_thorax-2024-222059v1.5","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-024-01819-2"},{"key":"2026052010201446000_thorax-2024-222059v1.6","doi-asserted-by":"crossref","unstructured":"Mayr CH , Santacruz D , Jarosch S , et al . Spatial transcriptomic characterization of pathologic niches in IPF. Sci Adv 2024;10. doi:10.1126\/sciadv.adl5473","DOI":"10.1126\/sciadv.adl5473"},{"key":"2026052010201446000_thorax-2024-222059v1.7","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-025-02080-x"},{"key":"2026052010201446000_thorax-2024-222059v1.8","doi-asserted-by":"crossref","DOI":"10.1038\/srep46560","article-title":"The peripheral blood proteome signature of idiopathic pulmonary fibrosis is distinct from normal and is associated with novel immunological processes","volume":"7","author":"O\u2019Dwyer","year":"2017","journal-title":"Sci Rep"},{"key":"2026052010201446000_thorax-2024-222059v1.9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2017.11.007"},{"key":"2026052010201446000_thorax-2024-222059v1.10","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.cyto.2018.01.023","article-title":"CCL18 - Beyond chemotaxis","volume":"109","author":"Chenivesse","year":"2018","journal-title":"Cytokine"},{"key":"2026052010201446000_thorax-2024-222059v1.11","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201309-1592OC"},{"key":"2026052010201446000_thorax-2024-222059v1.12","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200502-244OC"},{"key":"2026052010201446000_thorax-2024-222059v1.13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0008959","article-title":"CD28 Down-Regulation on Circulating CD4 T-Cells Is Associated with Poor Prognoses of Patients with Idiopathic Pulmonary Fibrosis","volume":"5","author":"Gilani","year":"2010","journal-title":"PLoS ONE"},{"key":"2026052010201446000_thorax-2024-222059v1.14","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/s41385-018-0082-8","article-title":"Characterization of CD28null T cells in idiopathic pulmonary fibrosis","volume":"12","author":"Habiel","year":"2019","journal-title":"Mucosal Immunol"},{"key":"2026052010201446000_thorax-2024-222059v1.15","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2016.00516","article-title":"Skewed Lung CCR4 to CCR6 CD4+ T Cell Ratio in Idiopathic Pulmonary Fibrosis Is Associated with Pulmonary Function","volume":"7","author":"Adegunsoye","year":"2016","journal-title":"Front Immunol"},{"key":"2026052010201446000_thorax-2024-222059v1.16","doi-asserted-by":"publisher","DOI":"10.1172\/JCI4174"},{"key":"2026052010201446000_thorax-2024-222059v1.17","doi-asserted-by":"publisher","DOI":"10.1186\/1476-9255-4-14"},{"key":"2026052010201446000_thorax-2024-222059v1.18","doi-asserted-by":"crossref","DOI":"10.1186\/1465-9921-6-81","article-title":"CD8+ T lymphocytes in lung tissue from patients with idiopathic pulmonary fibrosis","volume":"6","author":"Daniil","year":"2005","journal-title":"Respir Res"},{"key":"2026052010201446000_thorax-2024-222059v1.19","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.molimm.2024.06.008","article-title":"Single-cell transcriptomics reveals CD8+ T cell structure and developmental trajectories in idiopathic pulmonary fibrosis","volume":"172","author":"Wei","year":"2024","journal-title":"Mol Immunol"},{"key":"2026052010201446000_thorax-2024-222059v1.20","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1165\/rcmb.2021-0418OC","article-title":"Multiplatform Single-Cell Analysis Identifies Immune Cell Types Enhanced in Pulmonary Fibrosis","volume":"67","author":"Serezani","year":"2022","journal-title":"Am J Respir Cell Mol Biol"},{"key":"2026052010201446000_thorax-2024-222059v1.21","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2019.04.004"},{"key":"2026052010201446000_thorax-2024-222059v1.22","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/j.immuni.2017.05.005","article-title":"The Transcription Factor T-bet Limits Amplification of Type I IFN Transcriptome and Circuitry in T Helper 1 Cells","volume":"46","author":"Iwata","year":"2017","journal-title":"Immunity"},{"key":"2026052010201446000_thorax-2024-222059v1.23","doi-asserted-by":"crossref","first-page":"L92","DOI":"10.1152\/ajplung.2001.281.1.L92","article-title":"IL-12 attenuates bleomycin-induced pulmonary fibrosis","volume":"281","author":"Keane","year":"2001","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"2026052010201446000_thorax-2024-222059v1.24","doi-asserted-by":"publisher","DOI":"10.1038\/nri1412"},{"key":"2026052010201446000_thorax-2024-222059v1.25","first-page":"1001","article-title":"In vivo levels and in vitro production of interferon- in fibrosing interstitial lung diseases","volume":"96","author":"Furusho","year":"2002","journal-title":"Respir Med"},{"key":"2026052010201446000_thorax-2024-222059v1.26","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-4652(199605)167:2<290::AID-JCP13>3.0.CO;2-C"},{"key":"2026052010201446000_thorax-2024-222059v1.27","doi-asserted-by":"publisher","DOI":"10.1172\/JCI116015"},{"key":"2026052010201446000_thorax-2024-222059v1.28","doi-asserted-by":"publisher","DOI":"10.1084\/jem.194.6.809"},{"key":"2026052010201446000_thorax-2024-222059v1.29","doi-asserted-by":"publisher","DOI":"10.1038\/labinvest.2008.61"},{"key":"2026052010201446000_thorax-2024-222059v1.30","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.97.10040787"},{"key":"2026052010201446000_thorax-2024-222059v1.31","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2009.24.4.614"},{"key":"2026052010201446000_thorax-2024-222059v1.32","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1164\/rccm.201704-0784OC","article-title":"A phase 2 randomized controlled study of tralokinumab in subjects with idiopathic pulmonary fibrosis","volume":"197","author":"Parker","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"2026052010201446000_thorax-2024-222059v1.33","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02442-2019"},{"key":"2026052010201446000_thorax-2024-222059v1.34","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aar8356","article-title":"PD-1 up-regulation on CD4+ T cells promotes pulmonary fibrosis through STAT3-mediated IL-17A and TGF-\u03b21 production","volume":"10","author":"Celada","year":"2018","journal-title":"Sci Transl Med"},{"key":"2026052010201446000_thorax-2024-222059v1.35","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2011.166"},{"key":"2026052010201446000_thorax-2024-222059v1.36","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.cyto.2013.12.003","article-title":"Peripheral depletion of NK cells and imbalance of the Treg\/Th17 axis in idiopathic pulmonary fibrosis patients","volume":"66","author":"Galati","year":"2014","journal-title":"Cytokine"},{"key":"2026052010201446000_thorax-2024-222059v1.37","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2011.08.003"},{"key":"2026052010201446000_thorax-2024-222059v1.38","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/s41392-023-01471-y","article-title":"T cells in health and disease","volume":"8","author":"Sun","year":"2023","journal-title":"Sig Transduct Target Ther"},{"key":"2026052010201446000_thorax-2024-222059v1.39","doi-asserted-by":"publisher","DOI":"10.1126\/science.1079490"},{"key":"2026052010201446000_thorax-2024-222059v1.40","doi-asserted-by":"publisher","DOI":"10.1186\/sl2931-017-0653-3"},{"key":"2026052010201446000_thorax-2024-222059v1.41","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200812-1936OC"},{"key":"2026052010201446000_thorax-2024-222059v1.42","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1801330"},{"key":"2026052010201446000_thorax-2024-222059v1.43","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-021-00519-w"},{"key":"2026052010201446000_thorax-2024-222059v1.44","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2019.01.008"},{"key":"2026052010201446000_thorax-2024-222059v1.45","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2013.10.054"},{"key":"2026052010201446000_thorax-2024-222059v1.46","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2404737"},{"key":"2026052010201446000_thorax-2024-222059v1.47","first-page":"3819","article-title":"Evidence for a critical role for IL-2 in CD40-mediated activation of naive B cells by primary CD4 T cells","volume":"28","author":"Johnson-L\u00e9ger","year":"1998","journal-title":"Eur J Immunol"},{"key":"2026052010201446000_thorax-2024-222059v1.48","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1201678"},{"key":"2026052010201446000_thorax-2024-222059v1.49","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2021.07.015"},{"key":"2026052010201446000_thorax-2024-222059v1.50","doi-asserted-by":"publisher","DOI":"10.1038\/nri1572"},{"key":"2026052010201446000_thorax-2024-222059v1.51","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1203476"},{"key":"2026052010201446000_thorax-2024-222059v1.52","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1186\/s12931-019-1195-7","article-title":"Enhanced Bruton\u2019s tyrosine kinase in B-cells and autoreactive IgA in patients with idiopathic pulmonary fibrosis","volume":"20","author":"Heukels","year":"2019","journal-title":"Respir Res"},{"key":"2026052010201446000_thorax-2024-222059v1.53","doi-asserted-by":"publisher","DOI":"10.1002\/emmm.201100604"},{"key":"2026052010201446000_thorax-2024-222059v1.54","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201611-2263OC"},{"key":"2026052010201446000_thorax-2024-222059v1.55","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.181.1.756"},{"key":"2026052010201446000_thorax-2024-222059v1.56","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201203-0506OC"},{"key":"2026052010201446000_thorax-2024-222059v1.57","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.cca.2014.03.027","article-title":"Detection of anti-periplakin auto-antibodies during idiopathic pulmonary fibrosis","volume":"433","author":"Mignot","year":"2014","journal-title":"Clin Chim Acta"},{"key":"2026052010201446000_thorax-2024-222059v1.58","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201001-0076OC"},{"key":"2026052010201446000_thorax-2024-222059v1.59","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0076451","article-title":"Type V collagen induced tolerance suppresses collagen deposition, TGF-\u03b2 and associated transcripts in pulmonary fibrosis","volume":"8","author":"Vittal","year":"2013","journal-title":"PLoS One"},{"key":"2026052010201446000_thorax-2024-222059v1.60","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2249.2002.01811.x"},{"key":"2026052010201446000_thorax-2024-222059v1.61","doi-asserted-by":"publisher","DOI":"10.1007\/s004080000020"},{"key":"2026052010201446000_thorax-2024-222059v1.62","doi-asserted-by":"publisher","DOI":"10.1007\/PL00007649"},{"key":"2026052010201446000_thorax-2024-222059v1.63","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/icb.2017.22","article-title":"Idiopathic pulmonary fibrosis and a role for autoimmunity","volume":"95","author":"Hoyne","year":"2017","journal-title":"Immunol Cell Biol"},{"key":"2026052010201446000_thorax-2024-222059v1.64","doi-asserted-by":"crossref","first-page":"202102381","DOI":"10.1183\/13993003.02381-2021","article-title":"Autoantibodies are associated with disease progression in idiopathic pulmonary fibrosis","volume":"61","author":"Koether","year":"2023","journal-title":"Eur Respir J"},{"key":"2026052010201446000_thorax-2024-222059v1.65","doi-asserted-by":"crossref","first-page":"108345","DOI":"10.1016\/j.isci.2023.108345","article-title":"Mass spectrometry-based autoimmune profiling reveals predictive autoantigens in idiopathic pulmonary fibrosis","volume":"26","author":"Leuschner","year":"2023","journal-title":"iScience"},{"key":"2026052010201446000_thorax-2024-222059v1.66","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2424986122","article-title":"Antibody reactivity against EBNA1 and GlialCAM differentiates multiple sclerosis patients from healthy controls","volume":"122","author":"Sattarnezhad","year":"2025","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026052010201446000_thorax-2024-222059v1.67","doi-asserted-by":"crossref","first-page":"5271","DOI":"10.3390\/ijms252011096","article-title":"Epitope Spreading in Immune-Mediated Glomerulonephritis: The Expanding Target","volume":"25","author":"Strizzi","year":"2024","journal-title":"Int J Mol Sci"},{"key":"2026052010201446000_thorax-2024-222059v1.68","doi-asserted-by":"crossref","first-page":"106992","DOI":"10.1016\/j.rmed.2022.106992","article-title":"Acute exacerbation in antineutrophil cytoplasmic antibody-associated interstitial lung disease: Clinical features and risk factors","volume":"203","author":"Otsuka","year":"2022","journal-title":"Respir Med"},{"key":"2026052010201446000_thorax-2024-222059v1.69","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200703-463PP"},{"key":"2026052010201446000_thorax-2024-222059v1.70","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9103070","article-title":"Rituximab in the Treatment of Interstitial Lung Disease Associated with Autoimmune Diseases: Experience from a Single Referral Center and Literature Review","volume":"9","author":"Atienza-Mateo","year":"2020","journal-title":"J Clin Med"},{"key":"2026052010201446000_thorax-2024-222059v1.71","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0260345","article-title":"Correlates of survival after autoantibody reduction therapy for acute IPF exacerbations","volume":"16","author":"Kulkarni","year":"2021","journal-title":"PLoS One"},{"key":"2026052010201446000_thorax-2024-222059v1.72","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200702-220OC"},{"key":"2026052010201446000_thorax-2024-222059v1.73","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-204522"},{"key":"2026052010201446000_thorax-2024-222059v1.74","doi-asserted-by":"publisher","DOI":"10.1111\/resp.12214"},{"key":"2026052010201446000_thorax-2024-222059v1.75","doi-asserted-by":"publisher","DOI":"10.1002\/art.24249"},{"key":"2026052010201446000_thorax-2024-222059v1.76","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1093\/rheumatology\/kex072","article-title":"Effect of rituximab on the progression of rheumatoid arthritis-related interstitial lung disease: 10 years\u2019 experience at a single centre","volume":"56","author":"Md Yusof","year":"2017","journal-title":"Rheumatology (Oxford)"},{"key":"2026052010201446000_thorax-2024-222059v1.77","doi-asserted-by":"crossref","DOI":"10.1186\/ar2965","article-title":"B cell depletion in diffuse progressive systemic sclerosis: safety, skin score modification and IL-6 modulation in an up to thirty-six months follow-up open-label trial","volume":"12","author":"Bosello","year":"2010","journal-title":"Arthritis Res Ther"},{"key":"2026052010201446000_thorax-2024-222059v1.78","doi-asserted-by":"crossref","DOI":"10.1111\/jcmm.70402","article-title":"Single Cell RNA-Seq Identifies Cell Subpopulations Contributing to Idiopathic Pulmonary Fibrosis in Humans","volume":"29","author":"Zhang","year":"2025","journal-title":"J Cell Mol Med"},{"key":"2026052010201446000_thorax-2024-222059v1.79","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.595811","article-title":"Disparate Interferon Signaling and Shared Aberrant Basaloid Cells in Single-Cell Profiling of Idiopathic Pulmonary Fibrosis and Systemic Sclerosis-Associated Interstitial Lung Disease","volume":"12","author":"Valenzi","year":"2021","journal-title":"Front Immunol"},{"key":"2026052010201446000_thorax-2024-222059v1.80","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.820347","article-title":"Fibroblasts From Idiopathic Pulmonary Fibrosis Induce Apoptosis and Reduce the Migration Capacity of T Lymphocytes","volume":"13","author":"Chavez-Galan","year":"2022","journal-title":"Front Immunol"},{"key":"2026052010201446000_thorax-2024-222059v1.81","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.28358"},{"key":"2026052010201446000_thorax-2024-222059v1.82","doi-asserted-by":"crossref","first-page":"6660","DOI":"10.21037\/jtd.2018.11.16","article-title":"Membrane PD-L1 expression and soluble PD-L1 plasma levels in idiopathic pulmonary fibrosis-a pilot study","volume":"10","author":"Jovanovic","year":"2018","journal-title":"J Thorac Dis"},{"key":"2026052010201446000_thorax-2024-222059v1.83","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10235562","article-title":"PD-L1 Expression in Patients with Idiopathic Pulmonary Fibrosis","volume":"10","author":"Kronborg-White","year":"2021","journal-title":"J Clin Med"},{"key":"2026052010201446000_thorax-2024-222059v1.84","doi-asserted-by":"crossref","first-page":"L849","DOI":"10.1152\/ajplung.00028.2023","article-title":"IL-8 concurrently promotes idiopathic pulmonary fibrosis mesenchymal progenitor cell senescence and PD-L1 expression enabling escape from immune cell surveillance","volume":"324","author":"Yang","year":"2023","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"2026052010201446000_thorax-2024-222059v1.85","doi-asserted-by":"publisher","DOI":"10.1152\/ajplung.00151.2001"},{"key":"2026052010201446000_thorax-2024-222059v1.86","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)64282-4"},{"key":"2026052010201446000_thorax-2024-222059v1.87","doi-asserted-by":"crossref","first-page":"112768","DOI":"10.1016\/j.biopha.2022.112768","article-title":"PD-1\/PD-L1 inhibitor ameliorates silica-induced pulmonary fibrosis by maintaining systemic immune homeostasis","volume":"148","author":"Zhao","year":"2022","journal-title":"Biomedicine & Pharmacotherapy"},{"key":"2026052010201446000_thorax-2024-222059v1.88","first-page":"11450","article-title":"Targeted immunotherapy rescues pulmonary fibrosis by reducing activated fibroblasts and regulating alveolar cell profile","volume":"16","author":"Yan","year":"2025","journal-title":"Nat Commun"},{"key":"2026052010201446000_thorax-2024-222059v1.89","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.125326","article-title":"PD-L1 on invasive fibroblasts drives fibrosis in a humanized model of idiopathic pulmonary fibrosis","volume":"4","author":"Geng","year":"2019","journal-title":"JCI Insight"},{"key":"2026052010201446000_thorax-2024-222059v1.90","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.immunol.15.1.535"},{"key":"2026052010201446000_thorax-2024-222059v1.91","doi-asserted-by":"publisher","DOI":"10.1038\/nri3369"},{"key":"2026052010201446000_thorax-2024-222059v1.92","doi-asserted-by":"publisher","DOI":"10.1038\/ni.1841"},{"key":"2026052010201446000_thorax-2024-222059v1.93","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.2200074"},{"key":"2026052010201446000_thorax-2024-222059v1.94","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2013.02.032"},{"key":"2026052010201446000_thorax-2024-222059v1.95","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2018.03.009"},{"key":"2026052010201446000_thorax-2024-222059v1.96","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.02082","article-title":"Complex Network of NKT Cell Subsets Controls Immune Homeostasis in Liver and Gut","volume":"9","author":"Marrero","year":"2018","journal-title":"Front Immunol"},{"key":"2026052010201446000_thorax-2024-222059v1.97","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20031389"},{"key":"2026052010201446000_thorax-2024-222059v1.98","doi-asserted-by":"publisher","DOI":"10.1172\/JCI31602"},{"key":"2026052010201446000_thorax-2024-222059v1.99","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2010.10.003"},{"key":"2026052010201446000_thorax-2024-222059v1.100","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1400699"},{"key":"2026052010201446000_thorax-2024-222059v1.101","doi-asserted-by":"publisher","DOI":"10.1002\/hep.27632"},{"key":"2026052010201446000_thorax-2024-222059v1.102","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1601399"},{"key":"2026052010201446000_thorax-2024-222059v1.103","doi-asserted-by":"publisher","DOI":"10.1038\/ni.2731"},{"key":"2026052010201446000_thorax-2024-222059v1.104","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0028648","article-title":"Distinct and overlapping effector functions of expanded human CD4+, CD8\u03b1+ and CD4-CD8\u03b1- invariant natural killer T cells","volume":"6","author":"O\u2019Reilly","year":"2011","journal-title":"PLoS ONE"},{"key":"2026052010201446000_thorax-2024-222059v1.105","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2001-12-0196"},{"key":"2026052010201446000_thorax-2024-222059v1.106","doi-asserted-by":"crossref","DOI":"10.3390\/cells13121073","article-title":"ScRNA-Seq Analyses Define the Role of GATA3 in iNKT Cell Effector Lineage Differentiation","volume":"13","author":"Tai","year":"2024","journal-title":"Cells"},{"key":"2026052010201446000_thorax-2024-222059v1.107","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20131038"},{"key":"2026052010201446000_thorax-2024-222059v1.108","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0801631105"},{"key":"2026052010201446000_thorax-2024-222059v1.109","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-018-0034-2"},{"key":"2026052010201446000_thorax-2024-222059v1.110","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20011908"},{"key":"2026052010201446000_thorax-2024-222059v1.111","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20011786"},{"key":"2026052010201446000_thorax-2024-222059v1.112","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0015412","article-title":"A Comprehensive Ex Vivo Functional Analysis of Human NKT Cells Reveals Production of MIP1-\u03b1 and MIP1-\u03b2, a Lack of IL-17, and a Th1-Bias in Males","volume":"5","author":"Snyder-Cappione","year":"2010","journal-title":"PLoS ONE"},{"key":"2026052010201446000_thorax-2024-222059v1.113","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.181.1.81"},{"key":"2026052010201446000_thorax-2024-222059v1.114","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abj8760","article-title":"A circulating subset of iNKT cells mediates antitumor and antiviral immunity","volume":"7","author":"Cui","year":"2022","journal-title":"Sci Immunol"},{"key":"2026052010201446000_thorax-2024-222059v1.115","doi-asserted-by":"publisher","DOI":"10.1002\/eji.200737838"},{"key":"2026052010201446000_thorax-2024-222059v1.116","doi-asserted-by":"publisher","DOI":"10.1038\/nri2451"},{"key":"2026052010201446000_thorax-2024-222059v1.117","doi-asserted-by":"publisher","DOI":"10.1038\/mi.2013.59"},{"key":"2026052010201446000_thorax-2024-222059v1.118","doi-asserted-by":"crossref","first-page":"1176724","DOI":"10.3389\/fimmu.2023.1176724","article-title":"Towards a better understanding of human iNKT cell subpopulations for improved clinical outcomes","volume":"14","author":"Look","year":"2023","journal-title":"Front Immunol"},{"key":"2026052010201446000_thorax-2024-222059v1.119","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20110522"},{"key":"2026052010201446000_thorax-2024-222059v1.120","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2015.06.025"},{"key":"2026052010201446000_thorax-2024-222059v1.121","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1038\/s41467-021-21574-w","article-title":"Transcriptome and chromatin landscape of iNKT cells are shaped by subset differentiation and antigen exposure","volume":"12","author":"Murray","year":"2021","journal-title":"Nat Commun"},{"key":"2026052010201446000_thorax-2024-222059v1.122","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.170.4.2083"},{"key":"2026052010201446000_thorax-2024-222059v1.123","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.177.8.5258"},{"key":"2026052010201446000_thorax-2024-222059v1.124","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201343937"},{"key":"2026052010201446000_thorax-2024-222059v1.125","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1159\/000362984","article-title":"Invariant natural killer T (iNKT) cells prevent autoimmunity, but induce pulmonary inflammation in cystic fibrosis","volume":"34","author":"Siegmann","year":"2014","journal-title":"Cell Physiol Biochem"},{"key":"2026052010201446000_thorax-2024-222059v1.126","doi-asserted-by":"publisher","DOI":"10.1038\/nm1770"},{"key":"2026052010201446000_thorax-2024-222059v1.127","doi-asserted-by":"publisher","DOI":"10.1038\/mi.2013.75"},{"key":"2026052010201446000_thorax-2024-222059v1.128","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000239","article-title":"Innate invariant NKT cells recognize Mycobacterium tuberculosis-infected macrophages, produce interferon-gamma, and kill intracellular bacteria","volume":"4","author":"Sada-Ovalle","year":"2008","journal-title":"PLoS Pathog"},{"key":"2026052010201446000_thorax-2024-222059v1.129","doi-asserted-by":"publisher","DOI":"10.1172\/JCI36264"},{"key":"2026052010201446000_thorax-2024-222059v1.130","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1002348"},{"key":"2026052010201446000_thorax-2024-222059v1.131","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0045348","article-title":"Direct Engagement of TLR4 in Invariant NKT Cells Regulates Immune Diseases by Differential IL-4 and IFN-\u03b3 Production in Mice","volume":"7","author":"Kim","year":"2012","journal-title":"PLoS ONE"},{"key":"2026052010201446000_thorax-2024-222059v1.132","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1260503","article-title":"Type 1 invariant natural killer T cells in chronic inflammation and tissue fibrosis","volume":"14","author":"Kumar","year":"2023","journal-title":"Front Immunol"},{"key":"2026052010201446000_thorax-2024-222059v1.133","first-page":"6146","article-title":"Natural killer T (NKT) cells attenuate bleomycin-induced pulmonary fibrosis by producing interferon","volume":"193","author":"Kim","year":"2014","journal-title":"J Immunol"},{"key":"2026052010201446000_thorax-2024-222059v1.134","article-title":"Treatment with -galactosylceramide attenuates the development of bleomycin-induced pulmonary fibrosis","volume":"169","author":"Kimura","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"2026052010201446000_thorax-2024-222059v1.135","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s10787-017-0383-7","article-title":"Protective role of NKT cells and macrophage M2-driven phenotype in bleomycin-induced pulmonary fibrosis","volume":"26","author":"Grabarz","year":"2018","journal-title":"Inflammopharmacology"},{"key":"2026052010201446000_thorax-2024-222059v1.136","doi-asserted-by":"publisher","DOI":"10.1126\/science.278.5343.1623"},{"key":"2026052010201446000_thorax-2024-222059v1.137","doi-asserted-by":"publisher","DOI":"10.1038\/ni.2347"},{"key":"2026052010201446000_thorax-2024-222059v1.138","doi-asserted-by":"publisher","DOI":"10.3109\/15412555.2015.1069806"},{"key":"2026052010201446000_thorax-2024-222059v1.139","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0153347","article-title":"Generation of Novel Traj18-Deficient Mice Lacking V\u03b114 Natural Killer T Cells with an Undisturbed T Cell Receptor \u03b1-Chain Repertoire","volume":"11","author":"Dashtsoodol","year":"2016","journal-title":"PLoS One"},{"key":"2026052010201446000_thorax-2024-222059v1.140","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1164\/rccm.202402-0288LE","article-title":"Type 1 Invariant Natural Killer T Cells Drive Lung Fibrosis","volume":"210","author":"Calamita","year":"2024","journal-title":"Am J Respir Crit Care Med"},{"key":"2026052010201446000_thorax-2024-222059v1.141","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M111.304758"},{"key":"2026052010201446000_thorax-2024-222059v1.142","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1800614"},{"key":"2026052010201446000_thorax-2024-222059v1.143","doi-asserted-by":"publisher","DOI":"10.1016\/j.imlet.2024.106910"},{"key":"2026052010201446000_thorax-2024-222059v1.144","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/nature11605","article-title":"MR1 presents microbial vitamin B metabolites to MAIT cells","volume":"491","author":"Kjer-Nielsen","year":"2012","journal-title":"Nature New Biol"},{"key":"2026052010201446000_thorax-2024-222059v1.145","doi-asserted-by":"publisher","DOI":"10.1084\/jem.187.6.885"},{"key":"2026052010201446000_thorax-2024-222059v1.146","doi-asserted-by":"publisher","DOI":"10.1111\/imcb.12021"},{"key":"2026052010201446000_thorax-2024-222059v1.147","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-08-303339"},{"key":"2026052010201446000_thorax-2024-222059v1.148","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-080719-015428"},{"key":"2026052010201446000_thorax-2024-222059v1.149","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201343509"},{"key":"2026052010201446000_thorax-2024-222059v1.150","doi-asserted-by":"publisher","DOI":"10.1038\/ni.3298"},{"key":"2026052010201446000_thorax-2024-222059v1.151","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0914839107"},{"key":"2026052010201446000_thorax-2024-222059v1.152","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-04450-y"},{"key":"2026052010201446000_thorax-2024-222059v1.153","doi-asserted-by":"publisher","DOI":"10.1002\/eji.202048645"},{"key":"2026052010201446000_thorax-2024-222059v1.154","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2015.01.014"},{"key":"2026052010201446000_thorax-2024-222059v1.155","first-page":"699988","article-title":"Mucosal Associated Invariant T Cells Were Activated and Polarized Toward Th17 in Chronic Obstructive Pulmonary Disease","volume":"12","author":"Qiu","year":"2021","journal-title":"Front Immunol"},{"key":"2026052010201446000_thorax-2024-222059v1.156","doi-asserted-by":"crossref","first-page":"115275","DOI":"10.1016\/j.celrep.2025.115275","article-title":"MAIT cells protect against sterile lung injury","volume":"44","author":"Zhang","year":"2025","journal-title":"Cell Rep"},{"key":"2026052010201446000_thorax-2024-222059v1.157","doi-asserted-by":"crossref","unstructured":"Unterman A , Zhao AY , Neumark N , et al . Single-cell profiling reveals immune aberrations in progressive idiopathic pulmonary fibrosis. Respiratory Medicine [Preprint] 2023. doi:10.1101\/2023.04.29.23289296","DOI":"10.1101\/2023.04.29.23289296"},{"key":"2026052010201446000_thorax-2024-222059v1.158","doi-asserted-by":"publisher","DOI":"10.1038\/s41385-018-0072-x"},{"key":"2026052010201446000_thorax-2024-222059v1.159","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.02656","article-title":"The Host Microbiota Contributes to Early Protection Against Lung Colonization by Mycobacterium tuberculosis","volume":"9","author":"Dumas","year":"2018","journal-title":"Front Immunol"},{"key":"2026052010201446000_thorax-2024-222059v1.160","doi-asserted-by":"publisher","DOI":"10.1126\/science.abm0594"},{"key":"2026052010201446000_thorax-2024-222059v1.161","doi-asserted-by":"crossref","first-page":"182050","DOI":"10.1172\/jci.insight.182050","article-title":"CAR-engineered cytolytic Tregs reverse pulmonary fibrosis and remodel the fibrotic niche with limited CRS","volume":"10","author":"Jiang","year":"2025","journal-title":"JCI Insight"},{"key":"2026052010201446000_thorax-2024-222059v1.162","doi-asserted-by":"crossref","first-page":"e83","DOI":"10.1016\/S2665-9913(24)00282-0","article-title":"CD19-targeting CAR T-cell therapy in patients with diffuse systemic sclerosis: a case series","volume":"7","author":"Auth","year":"2025","journal-title":"Lancet Rheumatol"},{"key":"2026052010201446000_thorax-2024-222059v1.163","doi-asserted-by":"crossref","first-page":"1607170","DOI":"10.3389\/fimmu.2025.1607170","article-title":"Risk factors for checkpoint inhibitor pneumonitis in lung cancer patients treated with immune checkpoint inhibitors: a systematic review and meta-analysis","volume":"16","author":"Zhou","year":"2025","journal-title":"Front Immunol"},{"key":"2026052010201446000_thorax-2024-222059v1.164","first-page":"938382","article-title":"Dosing Regimens of Immune Checkpoint Inhibitors: Attempts at Lower Dose, Less Frequency, Shorter Course","volume":"12","author":"Jiang","year":"2022","journal-title":"Front Oncol"},{"key":"2026052010201446000_thorax-2024-222059v1.165","doi-asserted-by":"crossref","first-page":"117141","DOI":"10.1016\/j.ejmech.2024.117141","article-title":"Small molecule inhibitors targeting PD-L1, CTLA4, VISTA, TIM-3, and LAG3 for cancer immunotherapy (2020-2024)","volume":"283","author":"Cheng","year":"2025","journal-title":"Eur J Med Chem"},{"key":"2026052010201446000_thorax-2024-222059v1.166","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2018.12.758"},{"key":"2026052010201446000_thorax-2024-222059v1.167","doi-asserted-by":"crossref","first-page":"150897","DOI":"10.1016\/j.tmrv.2025.150897","article-title":"Identifying Modifiers of CAR T-Cell Therapeutic Efficacy and Safety: A Systematic Review and Individual Patient Data Meta-Analysis","volume":"39","author":"Lalu","year":"2025","journal-title":"Transfus Med Rev"},{"key":"2026052010201446000_thorax-2024-222059v1.168","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2308917"},{"key":"2026052010201446000_thorax-2024-222059v1.169","doi-asserted-by":"crossref","DOI":"10.1126\/science.adl4793","article-title":"Engineering synthetic suppressor T cells that execute locally targeted immunoprotective programs","volume":"386","author":"Reddy","year":"2024","journal-title":"Science"}],"container-title":["Thorax"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/thorax-2024-222059","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T17:20:33Z","timestamp":1779297633000},"score":1,"resource":{"primary":{"URL":"https:\/\/thorax.bmj.com\/lookup\/doi\/10.1136\/thorax-2024-222059"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,20]]},"references-count":169,"alternative-id":["10.1136\/thorax-2024-222059"],"URL":"https:\/\/doi.org\/10.1136\/thorax-2024-222059","relation":{},"ISSN":["0040-6376","1468-3296"],"issn-type":[{"value":"0040-6376","type":"print"},{"value":"1468-3296","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,20]]}}}